Literature DB >> 10393701

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

M Tomana1, J Novak, B A Julian, K Matousovic, K Konecny, J Mestecky.   

Abstract

Circulating immune complexes (CICs) isolated from sera of patients with IgA nephropathy (IgAN) consist of undergalactosylated, mostly polymeric, and J chain-containing IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glycans of the hinge region of IgA1 heavy chains. Antibodies with such specificity occur in sera of IgAN patients, and in smaller quantities in patients with non-IgA proliferative glomerulonephritis and in healthy controls; they are present mainly in the IgG (predominantly IgG2 subclass), and less frequently in the IgA1 isotype. Their specificity for GalNAc was determined by reactivity with IgA1 myeloma proteins with enzymatically removed N-acetylneuraminic acid (NeuNAc) and galactose (Gal); removal of the O-linked glycans of IgA1 resulted in significantly decreased reactivity. Furthermore, IgA2 proteins that lack the hinge region with O-linked glycans but are otherwise structurally similar to IgA1 did not react with IgG or IgA1 antibodies. The re-formation of isolated and acid-dissociated CICs was inhibited more effectively by IgA1 lacking NeuNAc and Gal than by intact IgA1. Immobilized GalNAc and asialo-ovine submaxillary mucin (rich in O-linked glycans) were also effective inhibitors. Our results suggest that the deficiency of Gal in the hinge region of IgA1 molecules results in the generation of antigenic determinants containing GalNAc residues that are recognized by naturally occurring IgG and IgA1 antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393701      PMCID: PMC408399          DOI: 10.1172/JCI5535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  O-linked oligosaccharides from human serum immunoglobulin A1.

Authors:  M C Field; R A Dwek; C J Edge; T W Rademacher
Journal:  Biochem Soc Trans       Date:  1989-12       Impact factor: 5.407

2.  Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.

Authors:  A Tarkowski; C Lue; Z Moldoveanu; H Kiyono; J R McGhee; J Mestecky
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

Review 3.  Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

Authors:  J Mestecky; J R McGhee
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

4.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

Authors:  J Mestecky; M Tomana; P A Crowley-Nowick; Z Moldoveanu; B A Julian; S Jackson
Journal:  Contrib Nephrol       Date:  1993       Impact factor: 1.580

5.  Site of catabolism of autologous and heterologous IgA in non-human primates.

Authors:  Z Moldoveanu; I Moro; J Radl; S R Thorpe; K Komiyama; J Mestecky
Journal:  Scand J Immunol       Date:  1990-12       Impact factor: 3.487

6.  Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

Authors:  M Thurnher; S Rusconi; E G Berger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.

Authors:  M Thurnher; H Clausen; W Fierz; A Lanzavecchia; E G Berger
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

8.  Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain.

Authors:  H H Radeke; J E Gessner; P Uciechowski; H J Mägert; R E Schmidt; K Resch
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

9.  The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.

Authors:  E B Nikolova; M Tomana; M W Russell
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

Review 10.  IgA nephropathy.

Authors:  J H Galla
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

View more
  179 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

3.  Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

Authors:  M Shimizu; N P Nikolov; K Ueno; K Ohta; R M Siegel; A Yachie; F Candotti
Journal:  Clin Immunol       Date:  2011-10-19       Impact factor: 3.969

Review 4.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 5.  IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage.

Authors:  Cheng Zhu; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-06-10       Impact factor: 2.370

6.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

7.  Development of Animal Models of Human IgA Nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Jan Novak; Yasuhiko Tomino
Journal:  Drug Discov Today Dis Models       Date:  2014

8.  Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Authors:  Kazuo Takahashi; Archer D Smith; Knud Poulsen; Mogens Kilian; Bruce A Julian; Jiri Mestecky; Jan Novak; Matthew B Renfrow
Journal:  J Proteome Res       Date:  2011-12-29       Impact factor: 4.466

9.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

Review 10.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.